000			01965 a2200565 4500
005			20250513231914.0
264		0	_c20010222
008			200102s 0 0 eng d
022			_a0250-7005
040			_aNLM _beng _cNLM
100	1		_aFocan, C
245	0	0	_aImportance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer. _h[electronic resource]
260			_bAnticancer research _c
300			_a4665-72 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdjuvants, Immunologic _xadministration & dosage
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntimetabolites, Antineoplastic _xadministration & dosage
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aChi-Square Distribution
650	0	4	_aColonic Neoplasms _xdrug therapy
650	0	4	_aColorectal Neoplasms _xdrug therapy
650	0	4	_aDisease-Free Survival
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aInfusions, Intravenous
650	0	4	_aInjections, Intravenous
650	0	4	_aLeucovorin _xadministration & dosage
650	0	4	_aLevamisole _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aPortal System
650	0	4	_aRadiotherapy, Adjuvant
650	0	4	_aRectal Neoplasms _xdrug therapy
650	0	4	_aSurvival Rate
700	1		_aBury, J
700	1		_aBeauduin, M
700	1		_aHerman, M L
700	1		_aVindevoghel, A
700	1		_aLecomte, M
700	1		_aBrohée, D
700	1		_aCanon, J L
700	1		_aFocan-Henrard, D
773	0		_tAnticancer research _gvol. 20 _gno. 6C _gp. 4665-72
999			_c11143244 _d11143244